• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Masimo wins FDA clearance for wearable vital sign monitor

Masimo wins FDA clearance for wearable vital sign monitor

June 5, 2023 By Sean Whooley

Masimo RadiusVSM
The Radius VSM system. [Image courtesy of Masimo]
Masimo (Nasdaq:MASI) announced today that the FDA cleared its Radius VSM patient-worn, continuous, multi-parameter vital signs monitor.

Radius VSM enables physicians to monitor a range of physiological measurements. That includes Masimo SET pulse oximetry, noninvasive blood pressure, temperature, respiration rate and ECG.

Masimo said its monitor combines the reliability and accuracy of larger bedside monitors with the comfort and freedom of wearable devices. It enables ambulation and movement while ensuring patients remain continuously monitored. The company said it has the scalability to match each patient’s unique monitoring needs and level of acuity.

About the Masimo Radius VSM

Radius VSM, a modular, wearable device, enables providers to equip any hospital bed with comprehensive monitoring. They can quickly add or remove measurement technologies to match each monitoring scenario, leading to more personalized care.

It can operate as a self-contained device or connect wirelessly to Masimo bedside monitors. That includes Root and the Masimo Hospital Automation platform, simplifying workflows by automating patient data transfer to remote systems.

The system uses a multi-functional pod and a variety of modules and noninvasive sensors. It provides measurements for pulse oximetry, respiration rate, blood pressure and skin temperature. Radius VSM alerts clinicians to unsupervised patient movement and possible patient falls, plus preventable pressure injuries.

Masimo designed the ECG capabilities to use continuous six-lead monitoring with heart rate, respiration rate and lethal arrhythmia detection. It utilizes a single-patient-use, easy-to-apply, pre-connected three-electrode leadwire. The system’s rainbow acoustic monitoring capability also detects acoustic signals produced by airflow in the upper airway.

“Radius VSM’s unique scalability, versatility, advanced connectivity, and broad range of accurate and automated continuous measurements – all in a wearable device that can be quickly and easily deployed anywhere in the hospital – make it a game-changing tool for clinicians everywhere,” said Joe Kiani, Masimo founder and CEO. “Doctors, nurses, and patients in Europe are already experiencing the advantages of Radius VSM and we are excited to share them with U.S. hospitals now too.”

Filed Under: 510(k), Business/Financial News, Diagnostics, Food & Drug Administration (FDA), Health Technology, Hospital Care, Patient Monitoring, Regulatory/Compliance Tagged With: FDA, Masimo

More recent news

  • Endologix is now Rhevera Medical
  • iRhythm completes acquisition of VitalConnect
  • Medtronic taps Siemens Healthineers exec as new Cardiac Ablations Solutions VP
  • Stryker will have a new CEO next year
  • Zenflow nets $52M, Cook Medical deal for in-office enlarged prostate implant

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy